Genitourinary

Dr. Hamilton is a urologic oncologist at Princess Margaret Cancer Centre and Associate Professor in the Department of Surgery (Urology) at the University of Toronto, Canada.  His clinical and research interests are in prostate and testicular cancers, as well as genitourinary sarcomas.  He holds research funding from The Canadian Cancer Society Research Institute, Prostate Cancer Canada, Movember, The Canadian Urology Association Scholarship Foundation, and The Canadian Urological Oncology Group.

In prostate cancer, he is exploring the role of pharmacogenomics to personalize chemoprevention, with a particular interest in statin medications.  He has interest in oligometastatic prostate cancer and molecular imaging modalities, and serves as a co-principal investigator on the Canada-wide Translation Acceleration Grant sponsored by Movember and Prostate Cancer Canada.

In testicular cancer his interests include novel biomarkers and studying means to minimize treatment morbidity, including robotic surgery.  He has recently developed an innovative virtual clinic for men with testicular cancer on surveillance to minimize travel burden and costs, and enhance access to specialty care for patients outside the greater Toronto area. He is the Chair of the Research Steering Committee for Movember’s Global Action Plan in testicular cancer.

Dr. Hamilton trained at the University of Toronto; completed a Masters of Public Health at The University of North Carolina at Chapel Hill and a research fellowship at Duke University.  He completed fellowship at Memorial Sloan-Kettering Cancer Centre.